Description
Hyponatremia is one of the most common electrolyte disorders encountered in hospitalized patients, yet it remains frequently misdiagnosed and mistreated. This session will use real-world case discussions to highlight diagnostic pitfalls, differentiate key etiologies such as SIADH, hypovolemia, and drug-induced hyponatremia, and guide evidence-based evaluation strategies. Faculty will also review safe correction protocols, monitoring approaches, and prevention of complications like osmotic demyelination. Designed for internal medicine physicians and healthcare professionals, the webinar aims to provide practical bedside tools for confident and effective management of inpatient hyponatremia.
Summary Listen
- Hyponatremia, defined as serum sodium below 135 mmol/L, affects approximately 10% of hospitalized patients. It is categorized as mild (130-135 mmol/L), moderate (125-129 mmol/L), and profound (<124 mmol/L). Symptoms range from muscle cramps and nausea in outpatient settings to confusion and seizures in emergencies.
- Hyponatremia increases fracture risk and contributes to falls in the elderly, independently of osteoporosis. It can also worsen neurocognitive function and motor performance. The severity of symptoms is linked to the speed of hyponatremia development, with faster development leading to more significant brain swelling.
- Volume status is crucial for determining the etiology of hyponatremia and guides treatment. Conditions are classified as hypovolemic (reduced volume), hypervolemic (expanded volume), or euvolemic (normal volume). Dehydration should be managed with free water, while hypovolemia requires isotonic crystalloids.
- Etiologies of hypovolemic hyponatremia include GI loss, transdermal loss, adrenal insufficiency, renal salt wasting, cerebral salt wasting, and diuretics. Hypervolemic hyponatremia is associated with heart failure, liver cirrhosis, and nephrotic syndrome. Euvolemic hyponatremia causes include SIADH, primary polydipsia, tea and toast diet, and hypothyroidism.
- Baseline investigations for hyponatremia include glucose levels, lipid profile, thyroid function tests, liver function tests, urea, creatinine, uric acid, electrolytes (including potassium), random serum cortisol levels (or 8 AM cortisol), urine osmolality, urine sodium, urine potassium, and plasma osmolality.
- Serum osmolality helps differentiate true hyponatremia from pseudo-hyponatremia. A low serum osmolality (<280 mmol/kg) indicates true hyponatremia, while normal (282-295 mmol/kg) or high (>295 mmol/kg) osmolality suggests pseudo-hyponatremia or hypertonic hyponatremia. Urine osmolality differentiates between conditions with and without antidiuretic hormone involvement.
- Urinary sodium differentiates hyponatremia secondary to hypovolemia from SIADH. Urine sodium is typically >20-40 mEq/L in SIADH and <20 mEq/L in hypovolemia, although low sodium intake in SIADH can skew the results. Treatment principles depend on volume status, duration of hyponatremia (acute vs. chronic), symptoms, and etiology.
- Hypertonic saline is used to gradually correct hyponatremia, aiming for a sodium level increase of no more than 6 mmol/L in the first 6 hours or 10 mmol/L in the first 24 hours. Rapid correction can lead to osmotic demyelination syndrome. Offending medications, especially diuretics and antidepressants, should be stopped.
- Free water deficit is calculated using the formula: (Sodium - 140) / 140 * Total Body Water. Total body water is estimated as 50% of body weight in women and 60% in men. Free water clearance is calculated to determine ongoing water loss.
- Drug-induced hyponatremia can be caused by thiazide diuretics, loop diuretics, antidepressants, MAO inhibitors, proton pump inhibitors, antipsychotics, ACE inhibitors, antiepileptic drugs, and anticancer drugs. Medication review is important, especially in geriatric patients.
- Hyponatremia in heart failure patients (hypervolemic hyponatremia) is treated with diuretics. Management of hypervolemic hyponatremia includes diuretics to promote sodium excretion.
- Post-operative hyponatremia is associated with adverse outcomes. Causes include hypotonic fluid administration, hypovolemia, medications, comorbidities, and SIADH. Treatment includes fluid resuscitation for hypovolemia and free water restriction for SIADH. Post-operative electrolytes should be monitored before discharge.
- Schwartz-Bartter diagnostic criteria for SIADH include decreased serum osmolality (<275 mOsm/kg), euvolemia, urine osmolality >100 mOsm/kg, urinary sodium >40 mEq/L, normal thyroid and adrenal function, and exclusion of diuretics. Causes of SIADH include malignancies, pulmonary diseases, and central nervous system disorders.
- SIADH is distinguished from cerebral salt wasting (CSW) by ECF volume, blood urea, and hematocrit. Treatment for SIADH includes fluid restriction and furosemide, while CSW is treated with saline, sometimes with furosemide.
- Tolvaptan, a vasopressin receptor antagonist, can be used to correct hyponatremia in SIADH. It should be initiated carefully after removing fluid restrictions. Demeclocycline can also be used but has potential nephrotoxic effects.
- When suspecting hyponatremia, assess for acute symptoms and address the underlying cause. Electrolyte-free water clearance calculation is crucial for guiding fluid restriction. Equations are available for calculating corrected sodium, fractional excretion of sodium, serum osmolality, sodium deficit, and water deficit.
- Hyponatremia is a common and important clinical problem. Establishing the etiology and appropriate treatment improves outcomes. Guidelines for treatment and use of vaptans are essential.
Sample Certificate
About the Speakers
Dr. Meenakshi Kalyan
Consultant Internal Medicine, Manipal Hospital Whitefield, Bangalore
Comments
Comments
You must be logged in to leave a comment.